Abstract:Switching of vascular smooth muscle cells (VSMCs) from a contractile phenotype to a dedifferentiated (proliferative) phenotype contributes to neointima formation, which has been demonstrated to possess a tumour‐like nature. Dysregulated glucose and lipid metabolism is recognized as a hallmark of tumours but has not thoroughly been elucidated in neointima formation. Here, we investigated the cooperative role of glycolysis and fatty acid synthesis in vascular injury‐induced VSMC dedifferentiation and neointima formation. We found that the expression of hypoxia‐inducible factor‐1α (HIF‐1α) and its target 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase (PFKFB3), a critical glycolytic enzyme, were induced in the neointimal VSMCs of human stenotic carotid arteries and wire injured mouse carotid arteries. HIF‐1α overexpression to elevate glycolysis resulted in a decreased contractile phenotype while promoting VSMC proliferation and mTORC1 activation. Conversely, silencing Pfkfb3 had the opposite effects. Mechanistic studies demonstrated that glycolysis generates acetyl coenzyme A to fuel de novo fatty acid synthesis and mTORC1 activation. Whole‐transcriptome sequencing analysis confirmed the increased expression of PFKFB3 and fatty acid synthetase (FASN) in dedifferentiated VSMCs. More importantly, FASN upregulation was observed in neointimal VSMCs of human stenotic carotid arteries. Finally, interfering with PFKFB3 or FASN suppressed vascular injury‐induced mTORC1 activation, VSMC dedifferentiation, and neointima formation. Together, this study demonstrated that PFKFB3‐mediated glycolytic reprogramming and FASN‐mediated lipid metabolic reprogramming are distinctive features of VSMC phenotypic switching and could be potential therapeutic targets for treating vascular diseases with neointima formation. This article is protected by copyright. All rights reserved.

Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases

An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis

How vascular smooth muscle cell phenotype switching contributes to vascular disease

Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection

Vascular smooth muscle cell phenotypic switching in atherosclerosis

Dedifferentiation of Vascular Smooth Muscle Cells Upon Vessel Injury

An overview of potential molecular mechanisms involved in VSMC phenotypic modulation

Smooth Muscle Heterogeneity and Plasticity in Health and Aortic Aneurysmal Disease

Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis

New Insights into Phenotypic Switching of VSMCs Induced by Hyperhomocysteinemia: Role of Endothelin-1 Signaling

Interstitial Fluid Shear Stress Induces the Synthetic Phenotype Switching of VSMCs to Release Pro-calcified Extracellular Vesicles Via EGFR-MAPK-KLF5 Pathway

The Role of Vascular Smooth Muscle Cells in Arterial Remodeling: Focus on Calcification-Related Processes

Pressure and stiffness sensing together regulate vascular smooth muscle cell phenotype switching

The Phenotypic Responses of Vascular Smooth Muscle Cells Exposed to Mechanical Cues

Impaired Autophagy Mediates Hyperhomocysteinemia-Induced HA-VSMC Phenotypic Switching

Role of Vascular Smooth Muscle Cell Phenotypic Switching in Plaque Progression: A Hybrid Modeling Study

The Expanding Role of Alternative Splicing in Vascular Smooth Muscle Cell Plasticity

Vascular Smooth Muscle Cells Mechanosensitive Regulators and Vascular Remodeling

Differentiation And Application Of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells

Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia

Single-cell RNA sequencing reveals the vascular smooth muscle cell phenotypic landscape in aortic aneurysm